Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mace Dent Johnson Mace Dent Johnson is a writer on the kitchen team. To test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results